| Announce Date | 11/19/2025 |
| EPS Normalized Actual | $3.63 (Beat by $0.48) |
| EPS GAAP Actual | $3.63 (Beat by $0.48) |
| Revenue Actual | $1.4518B |
| Revenue Surprise | Beat by $1451.8M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jan 2029 | 19.22 | 18.3 | 18.74842 | 19.7367 | 1 |
| Jan 2028 | 13.24 | 26.56 | 12.97859 | 13.48557 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 3.67 | 3.67 | 1.4518B | 30.61% | 1451.8M |
| FQ3 2025 (Jul 2025) | 3.37 | 3.37 | 1.37794B | 12.69% | 1377.94M |
| FQ2 2025 (Apr 2025) | 2.11 | 2.11 | 1.25861B | 9.23% | 1258.61M |
| FQ1 2025 (Jan 2025) | 1.12 | 1.12 | 1.08453B | 12.18% | 1084.53M |
| FQ4 2024 (Oct 2024) | 2.39 | 2.39 | 1.00741B | -12.78% | 1007.41M |
| FQ3 2024 (Jul 2024) | 2.35 | 2.35 | 1.20306B | 30.98% | 1203.06M |
| FQ2 2024 (Apr 2024) | 2.15 | 2.15 | 1.14242B | 25.3% | 1142.42M |
| FQ1 2024 (Jan 2024) | 0.8 | 0.8 | 0.952455B | 100% | 952.46M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Jan 2028) | 2.11612 | -- | 2.06555 | 2.17042 | 2 |
| FQ4 2027 (Oct 2027) | 4.95819 | -- | 4.68316 | 5.25679 | 1 |
| FQ3 2027 (Jul 2027) | 4.75844 | -- | 4.49449 | 5.04501 | 1 |
| FQ2 2027 (Apr 2027) | 3.07586 | -- | 2.90524 | 3.2611 | 1 |
| FQ1 2027 (Jan 2027) | 1.70122 | -- | 1.68305 | 1.73138 | 3 |
| FQ4 2026 (Oct 2026) | 3.86755 | 5.11 | 3.82624 | 3.93611 | 3 |
| FQ3 2026 (Jul 2026) | 3.02714 | -11.33 | 2.92327 | 3.1373 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Jan 2028) | 1.47B | -- | 1.45B | 1.5B | 2 |
| FQ4 2027 (Oct 2027) | 1.73B | -- | 1.66B | 1.81B | 2 |
| FQ3 2027 (Jul 2027) | 1.68B | -- | 1.61B | 1.76B | 2 |
| FQ2 2027 (Apr 2027) | 1.54B | -- | 1.47B | 1.61B | 2 |
| FQ1 2027 (Jan 2027) | 1.26B | -- | 1.25B | 1.28B | 3 |
| FQ4 2026 (Oct 2026) | 1.55B | 6.28 | 1.54B | 1.57B | 3 |
| FQ3 2026 (Jul 2026) | 1.25B | -10.67 | 1.21B | 1.28B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 3.67 | 3.67 | 100% | |
| FQ3 2025 (Jul 2025) | 3.37 | 3.37 | 100% | |
| FQ2 2025 (Apr 2025) | 2.11 | 2.11 | 100% | |
| FQ1 2025 (Jan 2025) | 1.12 | 1.12 | 100% | |
| FQ4 2024 (Oct 2024) | 2.39 | 2.39 | 100% | |
| FQ3 2024 (Jul 2024) | 2.35 | 2.35 | 100% | |
| FQ2 2024 (Apr 2024) | 2.15 | 2.15 | 100% | |
| FQ1 2024 (Jan 2024) | 0.8 | 0.8 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0B | $1.45B | $1451.8M | 100% |
| FQ3 2025 (Jul 2025) | $0B | $1.38B | $1377.94M | 100% |
| FQ2 2025 (Apr 2025) | $0B | $1.26B | $1258.61M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $1.08B | $1084.53M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $1.01B | $1007.41M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $1.2B | $1203.06M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $1.14B | $1142.42M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.95B | $952.46M | 100% |